Category Archives: MS Treatment

When Steve Schade was diagnosed with multiple sclerosis in 2007, his family rallied around him without hesitation and started helping raise money in search of a cure. Just 34 years old at the time, the Highlands Ranch man used to enjoy his summer evenings playing softball. He began to have difficulty seeing the ball coming at him and suddenly could no longer see colors vividly. Things were almost gray scale, he said. About the same time he also began to feel numbness in his feet and knees. It felt like my legs were falling asleep, he said. I thought it was a circulation issue, that I had a pinched nerve. It wasnt apparent at all times, but was very gradual. With no specific diagnosis process available for multiple sclerosis, Schade underwent a years worth of tests, up to and including spinal taps, before receiving a probable MS diagnosis and beginning treatment. He has been on numerous drugs and steroids over the past six years, and does everything he can to stay sharp and active. Since the summer of 2008, one of the ways he has stayed active is by participating in the local Bike MS ride each year. Accompanied by … Continue reading →

BIDDEFORD, Maine, July 10, 2013 /PRNewswire/ --A new start/finish venue and exciting new coastal routes are the centerpieces of the 29th Annual Bike MS: Great Maine Getaway to be held Aug. 10-11, 2013. Organized by the National Multiple Sclerosis Society, the ride is moving to the University of New England (UNE) in Biddeford. MS (multiple sclerosis), an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain, and between the brain and body. More than 3,000 Maine residents live with the disease. (Logo: http://photos.prnewswire.com/prnh/20130710/NE45227LOGO ) Relocating to UNE creates great new routes featuring priceless views of the Atlantic Ocean. Route options available to riders are 25, 50, and 75 miles both Saturday and Sunday, plus a 100-mile century Saturday, making this year's Great Maine Getaway the perfect choice for all experience levels. During the two-day ride, cyclists and riders from Maine and across New England will experience the beauty of Maine's southern coastline, including an up close look at "Walkers Point," the summer home of President George H.W. Bush. "Moving to UNE and theMaine Coast turned a good ride into a great ride," said Alan Mooney,23-year veteran rider and chair of the volunteer-ledBike … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/8q59sw/firstimpact_fda) has announced the addition of the "FirstImpact: FDA approval of Aubagio" report to their offering. The report presents the key insights gained from this major poll of neurologists. The research and analysis identifies the main clinical and commercial factors expected to influence the drug's positioning against current and upcoming rivals in the MS treatment algorithm and examines Aubagio's future prescribing trends. The report also draws upon recent news coverage, analysis, and other market research undertaken, to provide background information about Aubagio, its development and its potential commercial positioning. The addition of key analyst opinion and consensus product forecasts for oral MS therapies provide a commercial perspective set against the views expressed by physicians. The report and related data pack provides a comprehensive analysis of physicians' reactions for industry professionals who need to immediately understand the impact of breaking news. Reasons To Buy - Obtain insights into neurologists' positioning of Aubagio - Review the expected impact of Aubagio on physician prescribing - Understand neurologist perceptions of Aubagio versus other launched and pipeline oral therapies through poll results - Identify the most influential factors for Aubagio prescribing - Compare the efficacy and safety of Aubagio versus … Continue reading →

Lucinda Creighton Psychiatrists opposed to the suicide clause in the abortion legislation have appealed to wavering TDs and to Ministers to look at the evidence-based research. At a press conference in Dublin yesterday three psychiatrists voiced their support for a proposed amendment, by Minister of State Lucinda Creighton, to the clause in the Protection of Life During Pregnancy Bill, to provide a treatment programme instead. Ms Creighton proposed a care pathway for women presenting as suicidal, including focused therapy at home, if they were still expressing suicidal thoughts after a number of assessments. Medical evidence Donegal-based psychiatrist Dr Eleanor Corcoran said treatment should be based on medical evidence and not on political considerations. Minister Creightons amendment is consistent with all the evidence that we have from international research of what is effective from women who are in a very vulnerable state and who are suffering with depression, she said. We would hope that the other TDs and Ministers would look at whats in the best interests of women and look at the scientific research. Dr Bernie McCabe of the HSE Louth-Meath mental health service said: Our concern is about the lack of consideration of evidence in relation to the development … Continue reading →

LONDON, July 8,2013 /PRNewswire/ --GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or the "Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, is pleased to note the announcement from its partner Almirall S.A. that Sativex is now available in Italy as a prescription medicine for use in the treatment of moderate to severe spasticity in Multiple Sclerosis (MS) patients who have not responded adequately to other anti-spasticity medications. The launch follows receipt of full marketing authorization for Sativex by the Italian health authorities in May. The medicine is reimbursed by the Italian authorities as a Class H (hospital dispensed) medicine. The reimbursed price of the medicine granted by the authorities in Italy is consistent with the reimbursed Sativex price in Spain. "As one of the largest markets in Europe, the launch of Sativex in Italy is a key milestone in the commercialization of this important new medicine. Italy represents yet another addition to the growing number of countries in Europe in which Sativex is now available to treat MS spasticity, a particularly debilitating symptom of MS that is not adequately treated with currently available medications," stated Justin Gover, Chief Executive … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/67vpwd/multiple) has announced the addition of the "Multiple Sclerosis: KOL Insight" report to their offering. The past year has seen landmark changes in multiple sclerosis, with the launch of two new novel oral products, Tecfidera (dimethyl fumarate; Biogen Idec) and Aubagio (teriflunomide; Sanofi) joining the first oral MS therapy, Novartis's Gilenya (fingolimod). The arrival of these drugs is expected to revolutionise multiple sclerosis treatment and be a catalyst for unprecedented market growth. Driven by in-depth interviews with the world's leading multiple sclerosis KOLs, Therapy Trends: Multiple Sclerosis uncovers how the current treatment landscape will be impacted by significant future events, with particular focus on pipeline therapies and how these will modify the way MS is managed by neurologists in the future. Key Features - This report cuts to the heart of market-changing events and eliminate superfluous background information so you can focus on developments of greatest strategic impact and reduce your reaction time. - The unique thought-leader selection matrix identifies the most influential KOLs in MS to deliver the perspectives vital in giving you a competitive edge, enabling informed decision-making and planning. - Detailed analysis of marketed and pipeline drugs helps you understand the products … Continue reading →

A women's rights group has accused Prime Minister Kevin Rudd of treachery for his treatment of predecessor Julia Gillard. The Victorian Women's Trust has placed full-page advertisements in four Australian newspapers praising Ms Gillard's achievements and slamming both Labor and the Liberal parties for their actions over the past three years. The statement says Mr Rudd orchestrated a treacherous "seek-and-destroy" mission against Ms Gillard, while Tony Abbott made opportunistic appeals to people's prejudices. The trust's Mary Crooks says the past three years were poisonous and led to a great loss of civility and decency. "We just want to put on the public record early in the piece the fact that this was a successful minority government, led by her (Gillard)," Ms Crooks said. "I would really urge people to start asking some questions - what have we learned about all this - and address the need to restore respect and civility in our political discourse." The advertisement also accuses seasoned reporters of becoming players in an aggressive campaign of sexist and chauvinistic abuse. Ms Crooks says the mainstream media failed to engage in dispassionate reporting. "I think there's been a hostile media, by and large, over the last three years, … Continue reading →

(PRWEB) July 02, 2013 Freedom Institute announced today the appointment of Rachel Russell as its Chief Clinical Officer. In this role, Ms. Russell will be responsible for supervising Freedom Institutes clinical team, overseeing the client service process, developing and integrating new programs and modalities, building relationships with other treatment centers, staff development and compliance. Working closely with Freedom Institutes leadership team and senior counselors, Ms. Russell will support the ongoing integration of family work into chemical dependency treatment, which is at the core of Freedom Institute's philosophy. She also will work with the clinical team to further build Freedom Institutes adolescent and school programs, helping to expand Freedom Institute and its programs overall. Ms. Russell takes over the role from Michael Noth, who has been Freedom Institutes Clinical Director since 2007. Mr. Noth will remain as a Senior Counselor with Freedom Institute, working side by side with Ms. Russell to effect a smooth transition while devoting more time to building his private practice. Rachels reputation in the Freedom Institute community and in the field in general is stellar, said Bob Miller, chairman of the board of Freedom Institute. She has worked with youth and families throughout her career and brings … Continue reading →

Multiple sclerosis (MS) is a familiar enemy. Thousands of people ride for a cure for MS in cycling-related fundraising events every year, including one in New Bern each September. The neuro-muscular autoimmune disease affects more than half a million people nationwide, some with crippling effects, and so far research has not pinned down a cause or cure, but continues to find treatments to help many patients better cope with it. Geneva Best Horne of the Pleasant Hill community just outside New Bern was diagnosed with MS in 2006 after she didnt recover as quickly as doctors felt she should from a 2005 accident. When the diagnosis came down, Horne was advised that an option for treatment was weekly interferon injections, but I asked if could go natural, she said. She was already interested in exercise and had played basketball at the West Street and J.T. Barber schools as a girl. And she had moved to a healthy, more natural lifestyle years before, spurred on by Dr. Neil Bender, who started Eastern Carolina Internal Medicine (now CarolinaEast Internal Medicine) in Pollocksville. He told me you can take charge of your health or depend on medication for the rest of your life, … Continue reading →

RACHEL PORTER's husband Jon was diagnosed with MS ten years ago Now a new diet could help him cope with MS and maybe beat it Diet bans meat and dairy and most saturated fats By Rachel Porter PUBLISHED: 16:00 EST, 29 June 2013 | UPDATED: 16:08 EST, 29 June 2013 674 shares 53 View comments Every year, more than 2,500 Britons are told they have multiple sclerosis. If they ask what it means, theyre likely to be given the textbook definition: its a progressively disabling, incurable, neurological illness. Theyll be told that pain, disability and a range of distressing symptoms are in their future. How bad it gets, how quickly it happens its not possible to predict. But theres not a lot they can do, except take the drugs available. That was the experience of my husband, Jon, when he was diagnosed ten years ago. He has relapsing-remitting MS, which means symptoms appear during a relapse, then fade partially or completely. New hope: Rachel Porter and her husband Jon, who was diagnosed with MS ten years ago, hope the new diet can change it all Continue reading here: Why no meat, no dairy and meditation every day COULD be the … Continue reading →